StockData
CV Sciences, Inc. logo

CV Sciences, Inc. (CVSI) stock

CVSIOTCPharmaceutical PreparationsFiscal year ends December 31
Financials through Q3 FY2026, quarter ended Sep 30, 2026Last filing: 10-Q on Nov 13, 2026Score 7/30
$0.01−0.00 (-21.13%)

Close on Oct 19, 2026Market cap $2.53MP/E –Yield –

CV Sciences total debt

Total debt is short-term plus long-term borrowings on the balance sheet at the end of each period.

CV Sciences's total debt was $0 at Sep 30, 2026. For fiscal 2025 it was $1.65M, up 143.6% from the year before. The highest annual figure on record is $3.63M in fiscal 2020.

Annual total debt

PeriodPeriod endValueChange
FY2025Dec 31, 2025$1.65M+143.6%
FY2024Dec 31, 2024$677.00K+118.4%
FY2021Dec 31, 2021$310.00K-91.5%
FY2020Dec 31, 2020$3.63M–
FY2019Dec 31, 2019$0–
FY2018Dec 31, 2018$0-100.0%
FY2017Dec 31, 2017$850.00K–

Quarterly total debt

Change is against the same quarter a year earlier.

PeriodPeriod endValueChange
Q3 FY2026Sep 30, 2026$0-100.0%
Q2 FY2026Jun 30, 2026$18.00K-98.5%
Q1 FY2026Mar 31, 2026$72.00K-94.3%
Q4 FY2025Dec 31, 2025$1.65M+143.6%
Q3 FY2025Sep 30, 2025$955.00K+208.1%
Q2 FY2025Jun 30, 2025$1.23M–
Q1 FY2025Mar 31, 2025$1.27M-57.7%
Q4 FY2024Dec 31, 2024$677.00K-79.3%
Q4 FY2021Dec 31, 2021$310.00K-91.5%
Q3 FY2021Sep 30, 2021$0-100.0%
Q2 FY2021Jun 30, 2021$3.00M+3.2%
Q1 FY2021Mar 31, 2021$3.27M–
Q4 FY2020Dec 31, 2020$3.63M–
Q3 FY2020Sep 30, 2020$2.54M+199.2%
Q2 FY2020Jun 30, 2020$2.91M–
Q4 FY2019Dec 31, 2019$0–
Q4 FY2018Dec 31, 2018$0–
Q4 FY2017Dec 31, 2017$850.00K–

More CV Sciences figures

See a number that looks wrong?